View Document Preview and Link Document Date: 2014-01-06 23:51:33 Open Document File Size: 86,93 KB Share Result on Facebook
Company 1 ASCIA EDUCATION RESOURCES / ASCIA EDUCATION RESOURCES / / Continent Europe / / Country Australia / New Zealand / / / Event Product Issues / / IndustryTerm therapies for people with primary immune deficiency disease / therapy for other diseases / blood products / / MedicalCondition certain autoimmune diseases / rarely severe headaches / headaches / severe allergy / HIV / disease / primary immune deficiency disease / primary immune deficiency diseases / recurrent infections / immune thrombocytopenia / hives / Severe Combined Immune Deficiency / education@allergy / Hepatitis C / chronic infections / seldom reverse long term organ injury / Common Variable Immune Deficiency / antibody deficiency / infection / Guillain Barre syndrome / bronchiectasis / infections / Treat existing infections / Primary Immune Deficiency / wheezing / / MedicalTreatment Immunoglobulin therapies / Immunoglobulin therapy / antibody therapy / / Organization Immune Deficiencies Foundation of Australia / Australasian Society of Clinical Immunology and Allergy / Immune Deficiencies Foundation of New Zealand / / Product Immunoglobulin / antibodies / people / / Technology antibodies / / URL www.allergy.org.au / www.allergy.org.au/content/view/150/317 / www.idfaustralia.org / www.idfnz.org.nz / / SocialTag 
Immunoglobulin Replacement Therapy in Primary Immune Deficiency (PID) Diseases ASCIA EDUCATION RESOURCES (AER) PATIENT INFORMATION Immunoglobulin (antibody) replacement therapy is one of the most important and successful